img

Global Biosimilars & Follow-on-Biologics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biosimilars & Follow-on-Biologics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Biosimilars & Follow-on-Biologics market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Biosimilars & Follow-on-Biologics is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Biosimilars & Follow-on-Biologics is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Biosimilars & Follow-on-Biologics is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Biosimilars & Follow-on-Biologics include Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group and Biogen idec, Inc., etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Biosimilars & Follow-on-Biologics, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Biosimilars & Follow-on-Biologics by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Biosimilars & Follow-on-Biologics market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Biosimilars & Follow-on-Biologics market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)
By Type
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
By Application
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Biosimilars & Follow-on-Biologics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Biosimilars & Follow-on-Biologics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosimilars & Follow-on-Biologics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Biosimilars & Follow-on-Biologics Definition
1.2 Market by Type
1.2.1 Global Biosimilars & Follow-on-Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Human Growth Hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal Antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Peptide
1.2.9 Others
1.3 Market Segment by Application
1.3.1 Global Biosimilars & Follow-on-Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.3.4 Chronic and Autoimmune Diseases
1.3.5 Growth Hormone Deficiencies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Biosimilars & Follow-on-Biologics Sales
2.1 Global Biosimilars & Follow-on-Biologics Revenue Estimates and Forecasts 2018-2034
2.2 Global Biosimilars & Follow-on-Biologics Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Biosimilars & Follow-on-Biologics Revenue by Region
2.3.1 Global Biosimilars & Follow-on-Biologics Revenue by Region (2018-2024)
2.3.2 Global Biosimilars & Follow-on-Biologics Revenue by Region (2024-2034)
2.4 Global Biosimilars & Follow-on-Biologics Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Biosimilars & Follow-on-Biologics Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Biosimilars & Follow-on-Biologics Sales Quantity by Region
2.6.1 Global Biosimilars & Follow-on-Biologics Sales Quantity by Region (2018-2024)
2.6.2 Global Biosimilars & Follow-on-Biologics Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Biosimilars & Follow-on-Biologics Sales Quantity by Manufacturers
3.1.1 Global Biosimilars & Follow-on-Biologics Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Biosimilars & Follow-on-Biologics Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Biosimilars & Follow-on-Biologics Sales in 2022
3.2 Global Biosimilars & Follow-on-Biologics Revenue by Manufacturers
3.2.1 Global Biosimilars & Follow-on-Biologics Revenue by Manufacturers (2018-2024)
3.2.2 Global Biosimilars & Follow-on-Biologics Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Biosimilars & Follow-on-Biologics Revenue in 2022
3.3 Global Biosimilars & Follow-on-Biologics Sales Price by Manufacturers
3.4 Global Key Players of Biosimilars & Follow-on-Biologics, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biosimilars & Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biosimilars & Follow-on-Biologics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biosimilars & Follow-on-Biologics, Product Offered and Application
3.8 Global Key Manufacturers of Biosimilars & Follow-on-Biologics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Biosimilars & Follow-on-Biologics Sales Quantity by Type
4.1.1 Global Biosimilars & Follow-on-Biologics Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Biosimilars & Follow-on-Biologics Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Type (2018-2034)
4.2 Global Biosimilars & Follow-on-Biologics Revenue by Type
4.2.1 Global Biosimilars & Follow-on-Biologics Historical Revenue by Type (2018-2024)
4.2.2 Global Biosimilars & Follow-on-Biologics Forecasted Revenue by Type (2024-2034)
4.2.3 Global Biosimilars & Follow-on-Biologics Revenue Market Share by Type (2018-2034)
4.3 Global Biosimilars & Follow-on-Biologics Price by Type
4.3.1 Global Biosimilars & Follow-on-Biologics Price by Type (2018-2024)
4.3.2 Global Biosimilars & Follow-on-Biologics Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Biosimilars & Follow-on-Biologics Sales Quantity by Application
5.1.1 Global Biosimilars & Follow-on-Biologics Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Biosimilars & Follow-on-Biologics Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Application (2018-2034)
5.2 Global Biosimilars & Follow-on-Biologics Revenue by Application
5.2.1 Global Biosimilars & Follow-on-Biologics Historical Revenue by Application (2018-2024)
5.2.2 Global Biosimilars & Follow-on-Biologics Forecasted Revenue by Application (2024-2034)
5.2.3 Global Biosimilars & Follow-on-Biologics Revenue Market Share by Application (2018-2034)
5.3 Global Biosimilars & Follow-on-Biologics Price by Application
5.3.1 Global Biosimilars & Follow-on-Biologics Price by Application (2018-2024)
5.3.2 Global Biosimilars & Follow-on-Biologics Price Forecast by Application (2024-2034)
6 North America
6.1 North America Biosimilars & Follow-on-Biologics Sales by Company
6.1.1 North America Biosimilars & Follow-on-Biologics Revenue by Company (2018-2024)
6.1.2 North America Biosimilars & Follow-on-Biologics Sales Quantity by Company (2018-2024)
6.2 North America Biosimilars & Follow-on-Biologics Market Size by Type
6.2.1 North America Biosimilars & Follow-on-Biologics Sales Quantity by Type (2018-2034)
6.2.2 North America Biosimilars & Follow-on-Biologics Revenue by Type (2018-2034)
6.3 North America Biosimilars & Follow-on-Biologics Market Size by Application
6.3.1 North America Biosimilars & Follow-on-Biologics Sales Quantity by Application (2018-2034)
6.3.2 North America Biosimilars & Follow-on-Biologics Revenue by Application (2018-2034)
6.4 North America Biosimilars & Follow-on-Biologics Market Size by Country
6.4.1 North America Biosimilars & Follow-on-Biologics Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Biosimilars & Follow-on-Biologics Revenue by Country (2018-2034)
6.4.3 North America Biosimilars & Follow-on-Biologics Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biosimilars & Follow-on-Biologics Sales by Company
7.1.1 Europe Biosimilars & Follow-on-Biologics Sales Quantity by Company (2018-2024)
7.1.2 Europe Biosimilars & Follow-on-Biologics Revenue by Company (2018-2024)
7.2 Europe Biosimilars & Follow-on-Biologics Market Size by Type
7.2.1 Europe Biosimilars & Follow-on-Biologics Sales Quantity by Type (2018-2034)
7.2.2 Europe Biosimilars & Follow-on-Biologics Revenue by Type (2018-2034)
7.3 Europe Biosimilars & Follow-on-Biologics Market Size by Application
7.3.1 Europe Biosimilars & Follow-on-Biologics Sales Quantity by Application (2018-2034)
7.3.2 Europe Biosimilars & Follow-on-Biologics Revenue by Application (2018-2034)
7.4 Europe Biosimilars & Follow-on-Biologics Market Size by Country
7.4.1 Europe Biosimilars & Follow-on-Biologics Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Biosimilars & Follow-on-Biologics Revenue by Country (2018-2034)
7.4.3 Europe Biosimilars & Follow-on-Biologics Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Biosimilars & Follow-on-Biologics Sales by Company
8.1.1 China Biosimilars & Follow-on-Biologics Sales Quantity by Company (2018-2024)
8.1.2 China Biosimilars & Follow-on-Biologics Revenue by Company (2018-2024)
8.2 China Biosimilars & Follow-on-Biologics Market Size by Type
8.2.1 China Biosimilars & Follow-on-Biologics Sales Quantity by Type (2018-2034)
8.2.2 China Biosimilars & Follow-on-Biologics Revenue by Type (2018-2034)
8.3 China Biosimilars & Follow-on-Biologics Market Size by Application
8.3.1 China Biosimilars & Follow-on-Biologics Sales Quantity by Application (2018-2034)
8.3.2 China Biosimilars & Follow-on-Biologics Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Biosimilars & Follow-on-Biologics Sales by Company
9.1.1 APAC Biosimilars & Follow-on-Biologics Sales Quantity by Company (2018-2024)
9.1.2 APAC Biosimilars & Follow-on-Biologics Revenue by Company (2018-2024)
9.2 APAC Biosimilars & Follow-on-Biologics Market Size by Type
9.2.1 APAC Biosimilars & Follow-on-Biologics Sales Quantity by Type (2018-2034)
9.2.2 APAC Biosimilars & Follow-on-Biologics Revenue by Type (2018-2034)
9.3 APAC Biosimilars & Follow-on-Biologics Market Size by Application
9.3.1 APAC Biosimilars & Follow-on-Biologics Sales Quantity by Application (2018-2034)
9.3.2 APAC Biosimilars & Follow-on-Biologics Revenue by Application (2018-2034)
9.4 APAC Biosimilars & Follow-on-Biologics Market Size by Region
9.4.1 APAC Biosimilars & Follow-on-Biologics Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Biosimilars & Follow-on-Biologics Revenue by Region (2018-2034)
9.4.3 APAC Biosimilars & Follow-on-Biologics Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales by Company
10.1.1 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Market Size by Type
10.2.1 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Market Size by Application
10.3.1 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Market Size by Country
10.4.1 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Biosimilars & Follow-on-Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Novartis Biosimilars & Follow-on-Biologics Products and Services
11.1.5 Novartis Biosimilars & Follow-on-Biologics SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Information
11.2.2 Synthon Pharmaceuticals Overview
11.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Products and Services
11.2.5 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics SWOT Analysis
11.2.6 Synthon Pharmaceuticals Recent Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Information
11.3.2 Teva Pharmaceutical Industries Overview
11.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Products and Services
11.3.5 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics SWOT Analysis
11.3.6 Teva Pharmaceutical Industries Recent Developments
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Information
11.4.2 LG Life Sciences Overview
11.4.3 LG Life Sciences Biosimilars & Follow-on-Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 LG Life Sciences Biosimilars & Follow-on-Biologics Products and Services
11.4.5 LG Life Sciences Biosimilars & Follow-on-Biologics SWOT Analysis
11.4.6 LG Life Sciences Recent Developments
11.5 Celltrion
11.5.1 Celltrion Company Information
11.5.2 Celltrion Overview
11.5.3 Celltrion Biosimilars & Follow-on-Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Celltrion Biosimilars & Follow-on-Biologics Products and Services
11.5.5 Celltrion Biosimilars & Follow-on-Biologics SWOT Analysis
11.5.6 Celltrion Recent Developments
11.6 Biocon
11.6.1 Biocon Company Information
11.6.2 Biocon Overview
11.6.3 Biocon Biosimilars & Follow-on-Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Biocon Biosimilars & Follow-on-Biologics Products and Services
11.6.5 Biocon Biosimilars & Follow-on-Biologics SWOT Analysis
11.6.6 Biocon Recent Developments
11.7 Hospira
11.7.1 Hospira Company Information
11.7.2 Hospira Overview
11.7.3 Hospira Biosimilars & Follow-on-Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Hospira Biosimilars & Follow-on-Biologics Products and Services
11.7.5 Hospira Biosimilars & Follow-on-Biologics SWOT Analysis
11.7.6 Hospira Recent Developments
11.8 Merck Group
11.8.1 Merck Group Company Information
11.8.2 Merck Group Overview
11.8.3 Merck Group Biosimilars & Follow-on-Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Merck Group Biosimilars & Follow-on-Biologics Products and Services
11.8.5 Merck Group Biosimilars & Follow-on-Biologics SWOT Analysis
11.8.6 Merck Group Recent Developments
11.9 Biogen idec, Inc.
11.9.1 Biogen idec, Inc. Company Information
11.9.2 Biogen idec, Inc. Overview
11.9.3 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Products and Services
11.9.5 Biogen idec, Inc. Biosimilars & Follow-on-Biologics SWOT Analysis
11.9.6 Biogen idec, Inc. Recent Developments
11.10 Genentech (Roche Group)
11.10.1 Genentech (Roche Group) Company Information
11.10.2 Genentech (Roche Group) Overview
11.10.3 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Products and Services
11.10.5 Genentech (Roche Group) Biosimilars & Follow-on-Biologics SWOT Analysis
11.10.6 Genentech (Roche Group) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Biosimilars & Follow-on-Biologics Value Chain Analysis
12.2 Biosimilars & Follow-on-Biologics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biosimilars & Follow-on-Biologics Production Mode & Process
12.4 Biosimilars & Follow-on-Biologics Sales and Marketing
12.4.1 Biosimilars & Follow-on-Biologics Sales Channels
12.4.2 Biosimilars & Follow-on-Biologics Distributors
12.5 Biosimilars & Follow-on-Biologics Customers
13 Market Dynamics
13.1 Biosimilars & Follow-on-Biologics Industry Trends
13.2 Biosimilars & Follow-on-Biologics Market Drivers
13.3 Biosimilars & Follow-on-Biologics Market Challenges
13.4 Biosimilars & Follow-on-Biologics Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Biosimilars & Follow-on-Biologics Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Human Growth Hormone
Table 3. Major Manufacturers of Erythropoietin
Table 4. Major Manufacturers of Monoclonal Antibodies
Table 5. Major Manufacturers of Insulin
Table 6. Major Manufacturers of Interferon
Table 7. Major Manufacturers of Granulocyte-Colony Stimulating Factor
Table 8. Major Manufacturers of Peptide
Table 9. Major Manufacturers of Others
Table 10. Global Biosimilars & Follow-on-Biologics Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Biosimilars & Follow-on-Biologics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 12. Global Biosimilars & Follow-on-Biologics Revenue by Region (2018-2024) & (US$ Million)
Table 13. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Region (2018-2024)
Table 14. Global Biosimilars & Follow-on-Biologics Revenue by Region (2024-2034) & (US$ Million)
Table 15. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Region (2024-2034)
Table 16. Global Biosimilars & Follow-on-Biologics Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Pcs)
Table 17. Global Biosimilars & Follow-on-Biologics Sales by Region (2018-2024) & (K Pcs)
Table 18. Global Biosimilars & Follow-on-Biologics Sales Market Share by Region (2018-2024)
Table 19. Global Biosimilars & Follow-on-Biologics Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Biosimilars & Follow-on-Biologics Sales Market Share by Region (2024-2034)
Table 21. Global Biosimilars & Follow-on-Biologics Sales Quantity by Manufacturers (2018-2024) & (K Pcs)
Table 22. Global Biosimilars & Follow-on-Biologics Sales Quantity Share by Manufacturers (2018-2024)
Table 23. Global Biosimilars & Follow-on-Biologics Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 24. Global Biosimilars & Follow-on-Biologics Revenue Share by Manufacturers (2018-2024)
Table 25. Global Biosimilars & Follow-on-Biologics Price by Manufacturers 2018-2024 (USD/Pcs)
Table 26. Global Key Players of Biosimilars & Follow-on-Biologics, Industry Ranking, 2021 VS 2022
Table 27. Global Biosimilars & Follow-on-Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Biosimilars & Follow-on-Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars & Follow-on-Biologics as of 2022)
Table 29. Global Key Manufacturers of Biosimilars & Follow-on-Biologics, Manufacturing Base Distribution and Headquarters
Table 30. Global Key Manufacturers of Biosimilars & Follow-on-Biologics, Product Offered and Application
Table 31. Global Key Manufacturers of Biosimilars & Follow-on-Biologics, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Biosimilars & Follow-on-Biologics Sales Quantity by Type (2018-2024) & (K Pcs)
Table 34. Global Biosimilars & Follow-on-Biologics Sales Quantity by Type (2024-2034) & (K Pcs)
Table 35. Global Biosimilars & Follow-on-Biologics Sales Quantity Share by Type (2018-2024)
Table 36. Global Biosimilars & Follow-on-Biologics Sales Quantity Share by Type (2024-2034)
Table 37. Global Biosimilars & Follow-on-Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 38. Global Biosimilars & Follow-on-Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 39. Global Biosimilars & Follow-on-Biologics Revenue Share by Type (2018-2024)
Table 40. Global Biosimilars & Follow-on-Biologics Revenue Share by Type (2024-2034)
Table 41. Biosimilars & Follow-on-Biologics Price by Type (2018-2024) & (USD/Pcs)
Table 42. Global Biosimilars & Follow-on-Biologics Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 43. Global Biosimilars & Follow-on-Biologics Sales Quantity by Application (2018-2024) & (K Pcs)
Table 44. Global Biosimilars & Follow-on-Biologics Sales Quantity by Application (2024-2034) & (K Pcs)
Table 45. Global Biosimilars & Follow-on-Biologics Sales Quantity Share by Application (2018-2024)
Table 46. Global Biosimilars & Follow-on-Biologics Sales Quantity Share by Application (2024-2034)
Table 47. Global Biosimilars & Follow-on-Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 48. Global Biosimilars & Follow-on-Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 49. Global Biosimilars & Follow-on-Biologics Revenue Share by Application (2018-2024)
Table 50. Global Biosimilars & Follow-on-Biologics Revenue Share by Application (2024-2034)
Table 51. Biosimilars & Follow-on-Biologics Price by Application (2018-2024) & (USD/Pcs)
Table 52. Global Biosimilars & Follow-on-Biologics Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 53. North America Biosimilars & Follow-on-Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 54. North America Biosimilars & Follow-on-Biologics Sales Quantity by Company (2018-2024) & (K Pcs)
Table 55. North America Biosimilars & Follow-on-Biologics Sales Quantity by Type (2018-2024) & (K Pcs)
Table 56. North America Biosimilars & Follow-on-Biologics Sales Quantity by Type (2024-2034) & (K Pcs)
Table 57. North America Biosimilars & Follow-on-Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 58. North America Biosimilars & Follow-on-Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 59. North America Biosimilars & Follow-on-Biologics Sales Quantity by Application (2018-2024) & (K Pcs)
Table 60. North America Biosimilars & Follow-on-Biologics Sales Quantity by Application (2024-2034) & (K Pcs)
Table 61. North America Biosimilars & Follow-on-Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 62. North America Biosimilars & Follow-on-Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 63. North America Biosimilars & Follow-on-Biologics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 64. North America Biosimilars & Follow-on-Biologics Revenue by Country (2018-2024) & (US$ Million)
Table 65. North America Biosimilars & Follow-on-Biologics Revenue by Country (2024-2034) & (US$ Million)
Table 66. North America Biosimilars & Follow-on-Biologics Sales Quantity by Country (2018-2024) & (K Pcs)
Table 67. North America Biosimilars & Follow-on-Biologics Sales Quantity by Country (2024-2034) & (K Pcs)
Table 68. Europe Biosimilars & Follow-on-Biologics Sales Quantity by Company (2018-2024) & (K Pcs)
Table 69. Europe Biosimilars & Follow-on-Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 70. Europe Biosimilars & Follow-on-Biologics Sales Quantity by Type (2018-2024) & (K Pcs)
Table 71. Europe Biosimilars & Follow-on-Biologics Sales Quantity by Type (2024-2034) & (K Pcs)
Table 72. Europe Biosimilars & Follow-on-Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 73. Europe Biosimilars & Follow-on-Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 74. Europe Biosimilars & Follow-on-Biologics Sales Quantity by Application (2018-2024) & (K Pcs)
Table 75. Europe Biosimilars & Follow-on-Biologics Sales Quantity by Application (2024-2034) & (K Pcs)
Table 76. Europe Biosimilars & Follow-on-Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 77. Europe Biosimilars & Follow-on-Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 78. Europe Biosimilars & Follow-on-Biologics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 79. Europe Biosimilars & Follow-on-Biologics Revenue by Country (2018-2024) & (US$ Million)
Table 80. Europe Biosimilars & Follow-on-Biologics Revenue by Country (2024-2034) & (US$ Million)
Table 81. Europe Biosimilars & Follow-on-Biologics Sales Quantity by Country (2018-2024) & (K Pcs)
Table 82. Europe Biosimilars & Follow-on-Biologics Sales Quantity by Country (2024-2034) & (K Pcs)
Table 83. China Biosimilars & Follow-on-Biologics Sales Quantity by Company (2018-2024) & (K Pcs)
Table 84. China Biosimilars & Follow-on-Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 85. China Biosimilars & Follow-on-Biologics Sales Quantity by Type (2018-2024) & (K Pcs)
Table 86. China Biosimilars & Follow-on-Biologics Sales Quantity by Type (2024-2034) & (K Pcs)
Table 87. China Biosimilars & Follow-on-Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 88. China Biosimilars & Follow-on-Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 89. China Biosimilars & Follow-on-Biologics Sales Quantity by Application (2018-2024) & (K Pcs)
Table 90. China Biosimilars & Follow-on-Biologics Sales Quantity by Application (2024-2034) & (K Pcs)
Table 91. China Biosimilars & Follow-on-Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 92. China Biosimilars & Follow-on-Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 93. APAC Biosimilars & Follow-on-Biologics Sales Quantity by Company (2018-2024) & (K Pcs)
Table 94. APAC Biosimilars & Follow-on-Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 95. APAC Biosimilars & Follow-on-Biologics Sales Quantity by Type (2018-2024) & (K Pcs)
Table 96. APAC Biosimilars & Follow-on-Biologics Sales Quantity by Type (2024-2034) & (K Pcs)
Table 97. APAC Biosimilars & Follow-on-Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 98. APAC Biosimilars & Follow-on-Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 99. APAC Biosimilars & Follow-on-Biologics Sales Quantity by Application (2018-2024) & (K Pcs)
Table 100. APAC Biosimilars & Follow-on-Biologics Sales Quantity by Application (2024-2034) & (K Pcs)
Table 101. APAC Biosimilars & Follow-on-Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 102. APAC Biosimilars & Follow-on-Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 103. APAC Biosimilars & Follow-on-Biologics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 104. APAC Biosimilars & Follow-on-Biologics Revenue by Region (2018-2024) & (US$ Million)
Table 105. APAC Biosimilars & Follow-on-Biologics Revenue by Region (2024-2034) & (US$ Million)
Table 106. APAC Biosimilars & Follow-on-Biologics Sales Quantity by Region (2018-2024) & (K Pcs)
Table 107. APAC Biosimilars & Follow-on-Biologics Sales Quantity by Region (2024-2034) & (K Pcs)
Table 108. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity by Company (2018-2024) & (K Pcs)
Table 109. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity by Type (2018-2024) & (K Pcs)
Table 111. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity by Type (2024-2034) & (K Pcs)
Table 112. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity by Application (2018-2024) & (K Pcs)
Table 115. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity by Application (2024-2034) & (K Pcs)
Table 116. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 119. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Country (2018-2024) & (US$ Million)
Table 120. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue by Country (2024-2034) & (US$ Million)
Table 121. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity by Country (2018-2024) & (K Pcs)
Table 122. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity by Country (2024-2034) & (K Pcs)
Table 123. Novartis Company Information
Table 124. Novartis Description and Overview
Table 125. Novartis Biosimilars & Follow-on-Biologics Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 126. Novartis Biosimilars & Follow-on-Biologics Product and Services
Table 127. Novartis Biosimilars & Follow-on-Biologics SWOT Analysis
Table 128. Novartis Recent Developments
Table 129. Synthon Pharmaceuticals Company Information
Table 130. Synthon Pharmaceuticals Description and Overview
Table 131. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Product and Services
Table 133. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics SWOT Analysis
Table 134. Synthon Pharmaceuticals Recent Developments
Table 135. Teva Pharmaceutical Industries Company Information
Table 136. Teva Pharmaceutical Industries Description and Overview
Table 137. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Product and Services
Table 139. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics SWOT Analysis
Table 140. Teva Pharmaceutical Industries Recent Developments
Table 141. LG Life Sciences Company Information
Table 142. LG Life Sciences Description and Overview
Table 143. LG Life Sciences Biosimilars & Follow-on-Biologics Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 144. LG Life Sciences Biosimilars & Follow-on-Biologics Product and Services
Table 145. LG Life Sciences Biosimilars & Follow-on-Biologics SWOT Analysis
Table 146. LG Life Sciences Recent Developments
Table 147. Celltrion Company Information
Table 148. Celltrion Description and Overview
Table 149. Celltrion Biosimilars & Follow-on-Biologics Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Celltrion Biosimilars & Follow-on-Biologics Product and Services
Table 151. Celltrion Biosimilars & Follow-on-Biologics SWOT Analysis
Table 152. Celltrion Recent Developments
Table 153. Biocon Company Information
Table 154. Biocon Description and Overview
Table 155. Biocon Biosimilars & Follow-on-Biologics Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 156. Biocon Biosimilars & Follow-on-Biologics Product and Services
Table 157. Biocon Biosimilars & Follow-on-Biologics SWOT Analysis
Table 158. Biocon Recent Developments
Table 159. Hospira Company Information
Table 160. Hospira Description and Overview
Table 161. Hospira Biosimilars & Follow-on-Biologics Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 162. Hospira Biosimilars & Follow-on-Biologics Product and Services
Table 163. Hospira Biosimilars & Follow-on-Biologics SWOT Analysis
Table 164. Hospira Recent Developments
Table 165. Merck Group Company Information
Table 166. Merck Group Description and Overview
Table 167. Merck Group Biosimilars & Follow-on-Biologics Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 168. Merck Group Biosimilars & Follow-on-Biologics Product and Services
Table 169. Merck Group Biosimilars & Follow-on-Biologics SWOT Analysis
Table 170. Merck Group Recent Developments
Table 171. Biogen idec, Inc. Company Information
Table 172. Biogen idec, Inc. Description and Overview
Table 173. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 174. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Product and Services
Table 175. Biogen idec, Inc. Biosimilars & Follow-on-Biologics SWOT Analysis
Table 176. Biogen idec, Inc. Recent Developments
Table 177. Genentech (Roche Group) Company Information
Table 178. Genentech (Roche Group) Description and Overview
Table 179. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 180. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Product and Services
Table 181. Genentech (Roche Group) Biosimilars & Follow-on-Biologics SWOT Analysis
Table 182. Genentech (Roche Group) Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Biosimilars & Follow-on-Biologics Distributors List
Table 186. Biosimilars & Follow-on-Biologics Customers List
Table 187. Biosimilars & Follow-on-Biologics Market Trends
Table 188. Biosimilars & Follow-on-Biologics Market Drivers
Table 189. Biosimilars & Follow-on-Biologics Market Challenges
Table 190. Biosimilars & Follow-on-Biologics Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilars & Follow-on-Biologics Product Picture
Figure 2. Global Biosimilars & Follow-on-Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Biosimilars & Follow-on-Biologics Market Share by Type in 2022 & 2034
Figure 4. Human Growth Hormone Product Picture
Figure 5. Erythropoietin Product Picture
Figure 6. Monoclonal Antibodies Product Picture
Figure 7. Insulin Product Picture
Figure 8. Interferon Product Picture
Figure 9. Granulocyte-Colony Stimulating Factor Product Picture
Figure 10. Peptide Product Picture
Figure 11. Others Product Picture
Figure 12. Global Biosimilars & Follow-on-Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 13. Global Biosimilars & Follow-on-Biologics Market Share by Application in 2022 & 2034
Figure 14. Blood Disorders
Figure 15. Oncology Diseases
Figure 16. Chronic and Autoimmune Diseases
Figure 17. Growth Hormone Deficiencies
Figure 18. Others
Figure 19. Biosimilars & Follow-on-Biologics Report Years Considered
Figure 20. Global Biosimilars & Follow-on-Biologics Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 21. Global Biosimilars & Follow-on-Biologics Revenue 2018-2034 (US$ Million)
Figure 22. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 23. Global Biosimilars & Follow-on-Biologics Sales Quantity 2018-2034 (K Pcs)
Figure 24. Global Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Region (2018-2024)
Figure 25. Global Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Region (2024-2034)
Figure 26. North America Biosimilars & Follow-on-Biologics Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 27. North America Biosimilars & Follow-on-Biologics Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Europe Biosimilars & Follow-on-Biologics Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 29. Europe Biosimilars & Follow-on-Biologics Revenue YoY (2018-2034) & (US$ Million)
Figure 30. China Biosimilars & Follow-on-Biologics Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 31. China Biosimilars & Follow-on-Biologics Revenue YoY (2018-2034) & (US$ Million)
Figure 32. APAC Biosimilars & Follow-on-Biologics Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 33. APAC Biosimilars & Follow-on-Biologics Revenue YoY (2018-2034) & (US$ Million)
Figure 34. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 35. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue YoY (2018-2034) & (US$ Million)
Figure 36. The Top 10 and Top 5 Players Market Share by Biosimilars & Follow-on-Biologics Sales Quantity in 2022
Figure 37. The Top 10 and Top 5 Players Market Share by Biosimilars & Follow-on-Biologics Revenue in 2022
Figure 38. Biosimilars & Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 39. Global Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 40. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Type (2018-2034)
Figure 41. Global Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 42. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Application (2018-2034)
Figure 43. North America Biosimilars & Follow-on-Biologics Revenue Market Share by Company in 2022
Figure 44. North America Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Company in 2022
Figure 45. North America Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 46. North America Biosimilars & Follow-on-Biologics Revenue Market Share by Type (2018-2034)
Figure 47. North America Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 48. North America Biosimilars & Follow-on-Biologics Revenue Market Share by Application (2018-2034)
Figure 49. North America Biosimilars & Follow-on-Biologics Revenue Share by Country (2018-2034)
Figure 50. North America Biosimilars & Follow-on-Biologics Sales Quantity Share by Country (2018-2034)
Figure 51. U.S. Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 52. Canada Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 53. Europe Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Company in 2022
Figure 54. Europe Biosimilars & Follow-on-Biologics Revenue Market Share by Company in 2022
Figure 55. Europe Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 56. Europe Biosimilars & Follow-on-Biologics Revenue Market Share by Type (2018-2034)
Figure 57. Europe Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 58. Europe Biosimilars & Follow-on-Biologics Revenue Market Share by Application (2018-2034)
Figure 59. Europe Biosimilars & Follow-on-Biologics Revenue Share by Country (2018-2034)
Figure 60. Europe Biosimilars & Follow-on-Biologics Sales Quantity Share by Country (2018-2034)
Figure 61. Germany Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 62. France Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 63. U.K. Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 64. Italy Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 65. Russia Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 66. China Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Company in 2022
Figure 67. China Biosimilars & Follow-on-Biologics Revenue Market Share by Company in 2022
Figure 68. China Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 69. China Biosimilars & Follow-on-Biologics Revenue Market Share by Type (2018-2034)
Figure 70. China Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 71. China Biosimilars & Follow-on-Biologics Revenue Market Share by Application (2018-2034)
Figure 72. APAC Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Company in 2022
Figure 73. APAC Biosimilars & Follow-on-Biologics Revenue Market Share by Company in 2022
Figure 74. APAC Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 75. APAC Biosimilars & Follow-on-Biologics Revenue Market Share by Type (2018-2034)
Figure 76. APAC Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 77. APAC Biosimilars & Follow-on-Biologics Revenue Market Share by Application (2018-2034)
Figure 78. APAC Biosimilars & Follow-on-Biologics Revenue Share by Region (2018-2034)
Figure 79. APAC Biosimilars & Follow-on-Biologics Sales Quantity Share by Region (2018-2034)
Figure 80. Japan Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 81. South Korea Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 82. China Taiwan Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 83. Southeast Asia Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 84. India Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 85. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Company in 2022
Figure 86. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue Market Share by Company in 2022
Figure 87. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 88. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue Market Share by Type (2018-2034)
Figure 89. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 90. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue Market Share by Application (2018-2034)
Figure 91. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Sales Quantity Share by Country (2018-2034)
Figure 92. Middle East, Africa and Latin America Biosimilars & Follow-on-Biologics Revenue Share by Country (2018-2034)
Figure 93. Brazil Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 94. Mexico Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 95. Turkey Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 96. Israel Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 97. GCC Countries Biosimilars & Follow-on-Biologics Revenue (2018-2034) & (US$ Million)
Figure 98. Biosimilars & Follow-on-Biologics Value Chain
Figure 99. Biosimilars & Follow-on-Biologics Production Process
Figure 100. Channels of Distribution (Direct Vs Distribution)
Figure 101. Distributors Profiles
Figure 102. Bottom-up and Top-down Approaches for This Report
Figure 103. Data Triangulation
Figure 104. Key Executives Interviewed